Luxempart S.A. acquired 26% stake in Kestrel Vision.
March 29, 2023
Share
Luxempart S.A. (BDL:LXMPR) entered into an agreement to acquire 26% stake in Kestrel Vision on February 5, 2023. The transaction?s completion, which remains subject to customary regulatory approvals, is expected for late March 2023. The Group realizes world-wide sales in excess of ?260 million and an EBITDA in excess of ?40 million. Pierre Sader and Charles-Henri d'Hotelans of Rothschild et Cie acted as financial advisor to Caravelle. Driss Mernissi and Erwan Robertet of Natixis Partners acted as financial advisor to Luxempart. François Hellot and Isaure Sander of Ashurst acted as legal advisor to Caravelle. Henri Pieyre de Mandiargues and Antoine Ricol of MacDermott Will & Emery acted as legal advisor to Luxempart. Elisabeth Adam of Elvinger Hoss & Prussen acted as legal advisor to Luxempart. Alexandre Gaudin of GCA Cabinet d?Avocats acted as legal advisor to the Luxempart management. Emmanuel Delaby of Delaby & Dorison acted as legal advisor to the Luxempart management. Arnaud Thibésart, Victor Giorgianni, Arielle Ohayon-Cohen and Julie Givernaud of PwC conducted Financial & Tax VDD. Alexandre Menard, Constance Emmanuelli, Sébastien Chaigne and Hugo Azerad of Kanberi Strategy conducted Commercial VDD. François Hellot, Solène Guyon and Emmanuelle Pontnau-Faure of Ashurst LLP, financial advisory arm acted as a financial advisor for KESTREL Vision.
Luxempart S.A. (BDL:LXMPR) completed the acquisition of 26% stake in Kestrel Vision on March 30, 2023.
Luxempart SA is a Luxembourg-based investment company which invests in listed and private equity, as well as in private equity funds. The Company is active in Luxembourg, Belgium, France, Italy and Germany, where it manages a portfolio of listed and unlisted companies. Through Luxempart Capital Partners and Indufin Capital Partners (ICP), Luxempart also runs private equity activities. ICP is a joint-venture with the Belgian family holding Eik NV. The Company holds stakes in a number of private companies, including SES, RTL Group, Atenor, Foyer Finance, Foyer SA, SEO, PNE Wind, Pescanova, Mirato, Indufin Capital Partners - ICP Sicar, IEE, Quip, DS Care, Ekkio Capital, Thrombogenics, IP Sante domicile, Octopede Fonds private equity, among others. It also holds a majority stake in Euphaco (ABC Chemical).
LUXEMPART S.A. 
